JPH0532680A - Optical resolution of optically active glutaric acid ester derivative - Google Patents

Optical resolution of optically active glutaric acid ester derivative

Info

Publication number
JPH0532680A
JPH0532680A JP3214534A JP21453491A JPH0532680A JP H0532680 A JPH0532680 A JP H0532680A JP 3214534 A JP3214534 A JP 3214534A JP 21453491 A JP21453491 A JP 21453491A JP H0532680 A JPH0532680 A JP H0532680A
Authority
JP
Japan
Prior art keywords
glutaric acid
acid ester
salt
optically active
dehydroabietylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3214534A
Other languages
Japanese (ja)
Other versions
JP3272377B2 (en
Inventor
Kentaro Hirai
健太郎 平井
Tetsuo Okada
哲夫 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP21453491A priority Critical patent/JP3272377B2/en
Publication of JPH0532680A publication Critical patent/JPH0532680A/en
Application granted granted Critical
Publication of JP3272377B2 publication Critical patent/JP3272377B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PURPOSE:To perform optical resolution of a specific racemic mixed solution in high yield and optical purity by reacting the racemic mixed solution with (+)-dehydroabietylamine, thereby forming (+)-dehydroabietylamine salt of R(-)- glutaric acid ester. CONSTITUTION:A racemic mixed solution of a glutaric acid of formula [R<1> is hydroxyl-protecting group; R<2> is (substituted) lower alkyl; * represents asymmetric carbon atom] is treated with (+)-dehydroabietylamine to form (+)- dehydroabietylamine salt of R(+)-glutaric acid ester and effect the optical resolution of optically active glutaric acid ester derivative. The produced salt is subjected to salt-decomposition to recover R(-)-glutaric acid ester and S(+)- glutaric acid ester.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、各種医薬品の原料とし
て有用な光学活性な3−ヒドロキシグルタル酸モノエス
テルの製造法を提供する。例えば、光学活性なHMG−
CoA還元酵素阻害剤を高収率で大規模に製造しうるた
めには、本発明が提供する光学活性な3−ヒドロキシグ
ルタル酸モノエステルは極めて重要である。
FIELD OF THE INVENTION The present invention provides a method for producing an optically active 3-hydroxyglutaric acid monoester useful as a raw material for various pharmaceutical products. For example, optically active HMG-
The optically active 3-hydroxyglutarate monoester provided by the present invention is extremely important in order to be able to produce a CoA reductase inhibitor in high yield and on a large scale.

【0002】[0002]

【従来の技術】この種の光学活性体の製造法としては、
不斉合成法あるいは酵素によるエステル部分の加水分解
法などがよく知られている。しかしながら、従来用いら
れてきたこのような不斉合成法では、種々の特殊な試薬
を要したり、反応工程が繁雑であったりする。また、酵
素による方法では酵素の反応物の受容性や酵素反応の条
件設定に難しさがある。従って、これらの方法では光学
純度の高い活性体を容易に得られる例は余り知られてい
ない。
2. Description of the Related Art As a method for producing an optically active substance of this type,
Asymmetric synthesis methods and enzymatic hydrolysis methods of ester moieties are well known. However, such asymmetric synthesis methods conventionally used require various special reagents or require complicated reaction steps. Further, the method using an enzyme has difficulty in setting the acceptability of the reaction product of the enzyme and the condition setting of the enzyme reaction. Therefore, there are few known examples of easily obtaining an active substance having high optical purity by these methods.

【0003】[0003]

【発明が解決しようとする課題】光学純度の高い化合物
を得ることは、医薬品を始めとする種々の化合物の合成
にとって、極めて重要な意味を有する。本発明は、ラセ
ミ体である3−ヒドロキシグルタル酸モノエステルを光
学分割することにより、光学活性体を効率良く取得する
方法である。
Obtaining a compound having a high optical purity is extremely important for the synthesis of various compounds including pharmaceuticals. The present invention is a method for efficiently obtaining an optically active substance by optically resolving a racemic 3-hydroxyglutarate monoester.

【0004】[0004]

【課題を解決するための手段】本発明者らは、前述の事
情を鋭意研究した結果、中間体として有用な光学活性体
を得るための光学分割法を見出した。即ち、本発明は式
I:
Means for Solving the Problems As a result of intensive studies on the above circumstances, the present inventors have found an optical resolution method for obtaining an optically active substance useful as an intermediate. That is, the invention provides formula I:

【化2】 (式中、R1はヒドロキシ保護基、R2は置換基を有して
いてもよい低級アルキル、*は不斉炭素原子をそれぞれ
表わす。)で示されるラセミ化合物の光学分割法を提供
するものである。
[Chemical 2] (Wherein R 1 represents a hydroxy protecting group, R 2 represents a lower alkyl which may have a substituent, and * represents an asymmetric carbon atom, respectively). Is.

【0005】即ち、本製造法は下記方法により示され
る。ラセミ−3−tert−ブチルジメチルシリルオキシグ
ルタル酸モノメチルエステルに一方の光学活性な光学分
割剤を添加し、添加したのと同種の光学活性体を分離
し、更にその母液から他方の光学活性体を得る方法であ
る。更に詳しくは、ラセミ−3−tert−ブチルジメチル
シリルオキシグルタル酸モノメチルエステルに(+)−D
HAAを作用させることにより、R(-)−3−tert−ブ
チルジメチルシリルオキシグルタル酸モノメチルエステ
ルの(+)DHAA塩を得、該塩を塩分解することによ
り、R(-)−3−tert−ブチルジメチルシリルオキシグ
ルタル酸モノメチルエステル(I−1)を得る。更に
(+)−DHAA塩を分離した後、母液を処理することに
よりS(+)−3−tert−ブチルジメチルシリルオキシグ
ルタル酸モノメチルエステル(I−2)を得る方法であ
る。
That is, this manufacturing method is shown by the following method. One optically active optical resolving agent was added to racemic-3-tert-butyldimethylsilyloxyglutaric acid monomethyl ester, the optically active substance of the same kind as that added was separated, and the other optically active substance was separated from the mother liquor. Is the way to get. More specifically, racemic-3-tert-butyldimethylsilyloxyglutaric acid monomethyl ester has (+)-D
By reacting with HAA, a (+) DHAA salt of R (-)-3-tert-butyldimethylsilyloxyglutarate monomethyl ester is obtained, and the salt is decomposed to give R (-)-3-tert. -Butyldimethylsilyloxyglutarate monomethyl ester (I-1) is obtained. Further
After separating the (+)-DHAA salt, the mother liquor is treated to obtain S (+)-3-tert-butyldimethylsilyloxyglutarate monomethyl ester (I-2).

【0006】本明細書中、ヒドロキシ保護基としては、
メチル、tert−ブチル、アリル、ベンジル、テトラヒド
ロピラニル、tert−ブチルジメチルシリルオキシ、tert
−ブチルジフェニルシリルオキシなどのエ−テル形成保
護基、アセチル、ベンゾイルなどのエステル形成保護
基、メチルスルホニル、p−トルエンスルホニル、フェ
ニルスルホニルなどのスルホン酸エステル形成保護基な
どが挙げられるが、本発明においては、エ−テル形成保
護基、特にtert−ブチルジメチルシリルオキシが好まし
い。
In the present specification, the hydroxy protecting group includes
Methyl, tert-butyl, allyl, benzyl, tetrahydropyranyl, tert-butyldimethylsilyloxy, tert
Examples of the present invention include an ether-forming protective group such as -butyldiphenylsilyloxy, an ester-forming protective group such as acetyl and benzoyl, and a sulfonate ester-forming protective group such as methylsulfonyl, p-toluenesulfonyl and phenylsulfonyl. In, an ether-forming protecting group, especially tert-butyldimethylsilyloxy is preferred.

【0007】「置換基を有していてもよい低級アルキ
ル」とは、一般に直鎖状または分岐状の炭素原子1〜6
のアルキルを意味し、例えば、メチル、エチル、n−プ
ロピル、イソプロピル、n−ブチル、イソブチル、sec
−ブチル、tert−ブチル、n−ペンチル、イソペンチ
ル、ネオペンチル、tert−ペンチル、2−メチルブチ
ル、n−ヘキシルおよびイソヘキシルなどが挙げられ、
それぞれハロゲンまたはアミノ基で置換されていてもよ
い。
The term "lower alkyl which may have a substituent (s)" generally means a linear or branched carbon atom of 1 to 6
Of alkyl, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec
-Butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 2-methylbutyl, n-hexyl and isohexyl, and the like,
Each may be substituted with halogen or an amino group.

【0008】以下に実施例を示し、本発明を更に具体的
に説明するが、これらによって本発明の範囲は限定され
るものではない。実施例で用いられる略字は、以下に示
す意味を表わす。 Me:メチル Et:エチル TBDMS:tert−ブチルジメチルシリル DHAA:デヒドロアビエチルアミン
The present invention will be described in more detail with reference to the following examples, which should not be construed as limiting the scope of the present invention. The abbreviations used in the examples have the following meanings. Me: Methyl Et: Ethyl TBDMS: tert-Butyldimethylsilyl DHAA: Dehydroabietylamine

【化3】 [Chemical 3]

【0009】参考例 (±)−3−tert−ブチルジメチルシリルオキシグルタ
ル酸モノメチルエステル
Reference Example (±) -3-tert-butyldimethylsilyloxygluta
Acid monomethyl ester 1

【化4】 粗製酸無水物30.0gを500mlのメタノ−ルに溶解
し、4時間還流する。減圧下で乾固し残分をトルエンに
溶解しシリカゲルカラムクロマトグラフィ−(トルエン
/酢酸エチル=4/1)にて付し、溶出物を減圧下で濃
縮し、残分をペンタンから氷冷下で結晶化させて目的化
合物27.2gを無色結晶として得られる(融点:54
〜55℃) IR(Nujol):1700, 1730 cm-1 元素分析値(%)C12H24O5Siとして 計算値:C,52.12; H,8.75 実験値:C,51.90; H,8.721 HNMR(CDCl3, 200M)δ:0.07 (3H,s); 0.08 (3H,
s); 0.85 (9H,s); 2.60(4H,m); 3.68 (3H,s); 4.55 (1
H,m)
[Chemical 4] 30.0 g of crude acid anhydride are dissolved in 500 ml of methanol and refluxed for 4 hours. It was evaporated to dryness under reduced pressure, the residue was dissolved in toluene and subjected to silica gel column chromatography (toluene / ethyl acetate = 4/1), the eluate was concentrated under reduced pressure, and the residue was removed from pentane under ice cooling. Crystallization gives 27.2 g of the desired compound as colorless crystals (melting point: 54
~55 ℃) IR (Nujol): 1700, 1730 cm -1 Elemental analysis (%) C 12 H calcd 24 O 5 Si: C, 52.12 ; H, 8.75 Found: C, 51.90; H, 8.72 1 HNMR (CDCl 3 , 200M) δ: 0.07 (3H, s); 0.08 (3H,
s); 0.85 (9H, s); 2.60 (4H, m); 3.68 (3H, s); 4.55 (1
H, m)

【0010】実施例1 R−(-)−3−tert−ブチルジメチルシリルオキシグル
タル酸モノメチルエステ (I−1)
Example 1 R-(-)-3-tert-butyldimethylsilyloxyglucurone
Tal acid monomethyl ester le (I-1)

【化5】 (1)R−(−)−3−tert−ブチルジメチルシリルオ
キシグルタル酸モノメチルエステルの(+)DHAA塩
(+)DHAA10.0g(36mmol)を50mlのメタ
ノ−ルに溶解し、そこへラセミの(±)−3−tert−ブ
チルジメチルシリルオキシグルタル酸モノメチルエステ
10.0g(35mmol)を加え、減圧下乾固する。
残分を100mlのペンタンに溶解し、種を植えて氷冷下
一晩静置する。析出した結晶を濾取して融点129〜1
30℃のR−(−)−3−tert−ブチルジメチルシリル
オキシグルタル酸モノメチルエステルの(+)DHAA
8.41gを得る。 [α]D+9.0°(C=2.0、 25.0℃、 MeOH)1 HNMR(200M,CDCl3)δ:0.04 (3H,s); 0.06
(3H,s); 0.84 (9H,s); 0.97(3H,s); 1.21 (6H,d,J=7H
z);1.22 (3H,s); 1.30〜1.85 (8H,m); 2.20〜2.95 (11
H,m); 3.64 (3H,s); 4.48 (1H,m); 6.68〜7.30 (3H,m) 元素分析値(%)C32H55NO5Siとして 計算値:C,68.40; H,9.87; N,2.49 実験値:C,68.18; H,9.74; N,2.57
[Chemical 5] (1) R-(-)-3-tert-butyldimethylsilylio
(+) DHAA salt of monomethyl xyglutaric acid ester
10.0 g (36 mmol) of 2 (+) DHAA was dissolved in 50 ml of methanol, and 10.0 g (35 mmol) of racemic (±) -3-tert-butyldimethylsilyloxyglutaric acid monomethyl ester 1 was added thereto. Dry to dryness under reduced pressure.
The residue is dissolved in 100 ml of pentane, seeds are planted, and the mixture is allowed to stand under ice cooling overnight. The precipitated crystals are collected by filtration and have a melting point of 129 to 1
(+) DHAA of R-(−)-3-tert-butyldimethylsilyloxyglutarate monomethyl ester at 30 ° C.
8.41 g of salt 2 are obtained. [Α] D + 9.0 ° (C = 2.0, 25.0 ° C., MeOH) 1 HNMR (200M, CDCl 3 ) δ: 0.04 (3H, s); 0.06
(3H, s); 0.84 (9H, s); 0.97 (3H, s); 1.21 (6H, d, J = 7H
z); 1.22 (3H, s); 1.30 ~ 1.85 (8H, m); 2.20 ~ 2.95 (11
H, m); 3.64 (3H, s); 4.48 (1H, m); 6.68 ~ 7.30 (3H, m) Elemental analysis value (%) Calculated as C 32 H 55 NO 5 Si: C, 68.40; H, 9.87; N, 2.49 Experimental value: C, 68.18; H, 9.74; N, 2.57

【0011】(2)(I−1)の合成 得られた(+)DHAA塩8.41gを100mlのエ
−テル中に懸濁し、そこへ4N-HCl−酢酸エチル溶液1
0mlを加えて撹拌する。更に、ペンタン100mlを加え
て、撹拌した後析出物を濾去し、濾液を減圧下で濃縮す
る。残分をトルエンに溶解して、シリカゲルカラムクロ
マトグラフィ−(トルエン/酢酸エチル=2/1)に付
して光学純度96%ee以上の油状物として目的化合物
(I−1)4.10gを得る。 [α]D−5.8°(C=4.1、 25.0℃、 MeOH)1 HNMR(200M, CDCl3)δ:0.07 (3H,S); 0.08 (3H,
s); 0.85 (9H,s); 2.60(4H,m); 3.68 (3H,s); 4.55 (1
H,m)
(2) Synthesis of (I-1) 8.41 g of the obtained (+) DHAA salt 2 was suspended in 100 ml of ether, and 4N-HCl-ethyl acetate solution 1 was added thereto.
Add 0 ml and stir. Further, 100 ml of pentane was added and stirred, the precipitate was filtered off, and the filtrate was concentrated under reduced pressure. The residue is dissolved in toluene and subjected to silica gel column chromatography (toluene / ethyl acetate = 2/1) to obtain 4.10 g of the target compound (I-1) as an oily substance having an optical purity of 96% ee or more. [Α] D −5.8 ° (C = 4.1, 25.0 ° C., MeOH) 1 HNMR (200M, CDCl 3 ) δ: 0.07 (3H, S); 0.08 (3H,
s); 0.85 (9H, s); 2.60 (4H, m); 3.68 (3H, s); 4.55 (1
H, m)

【0012】更に、光学純度は得られた化合物(I−
1)をR(+)1−フェネチルアミン−DCC−1−ヒ
ドロキシベンズトリアゾ−ルを用いて反応を行ない、H
eathcock(J.Org.Chem.,49,3657(1984))の方
法に準じてNMRより確認した。1 HNMR(200M, CDCl3)δ:0.07 (3H,s); 0.11 (3H,
s); 0.86 (9H,s); 1.47 (3H,d,J=7Hz); 2.35〜2.60 (4
H,m); 3.65 (3H,s); 4.50 (1H,m); 5.12 (1H,m); 6.57
(1H,br,d,J=7Hz); 7.32 (5H,m)
Further, the optical purity of the obtained compound (I-
1) is reacted with R (+) 1-phenethylamine-DCC-1-hydroxybenztriazol to give H
It was confirmed from NMR according to the method of ethcock (J. Org. Chem., 49 , 3657 (1984)). 1 HNMR (200M, CDCl 3 ) δ: 0.07 (3H, s); 0.11 (3H,
s); 0.86 (9H, s); 1.47 (3H, d, J = 7Hz); 2.35 ~ 2.60 (4
H, m); 3.65 (3H, s); 4.50 (1H, m); 5.12 (1H, m); 6.57
(1H, br, d, J = 7Hz); 7.32 (5H, m)

【0013】実施例2 S−(+)−3−tert−ブチルジメチルシリルオキシグル
タル酸モノメチルエス テル (I−2)
Example 2 S-(+)-3-tert-butyldimethylsilyloxyglucurone
Tal acid monomethyl Es ether (I-2)

【化6】 (1)S−(+)−3−tert−ブチルジメチルシリルオキ
シグルタル酸モノメチル エステルのS(-)−1−フェネ
チルアミン塩 化合物を得た際の母液を乾固して、200mlのエ−テ
ルに溶解する。撹拌下で4N−HCl−酢酸エチル溶液1
0mlを加えて、析出物を濾去し、濾液を濃縮してシリカ
ゲルカラムクロマトグラフィ−(トルエン/酢酸エチル
=2/1)に付し、溶出物を減圧下で濃縮する。残分を
20mlのペンタンにて溶解して−20℃下で二晩静置す
る。析出した結晶を濾去し、濾液中の溶媒を留去して光
学純度93%eeの油状物として粗(1−2)3.80
gを得る。この化合物1.00g(3.62mmol)、S-
(-)-1−フェネチルアミン440μl(3.50mmol)
を3mlのエ−テルに溶解し、更にペンタンを6ml加えて
1時間室温下で静置する。析出する結晶を濾取して化合
1.27gを得る(融点:104〜105℃)。 [α]D +11.2°(C=1.00, 24.0℃, MeOH) 元素分析値(%)C20H35NO5Siとして 計算値:C,60.42; H,8.87; N,3.52 実験値:C,60.34; H,8.85; N,3.611 HNMR(200M,CDCl3)δ:0.04 (3H,s); 0.05 (3H,
s); 0.84 (9H,s); 1.50 (3H,d,J=6Hz); 2.30〜2.60 (4
H,m); 3.65 (3H,s); 4.11 (1H,q.J=6Hz); 7.25〜7.40
(5H,m)
[Chemical 6] (1) S-(+)-3-tert-butyldimethylsilyloxy
Siglutaric acid monomethyl ester S (-)-1-phene
The mother liquor from which the tilamine salt 3 compound 2 was obtained is dried and dissolved in 200 ml of ether. 4N-HCl-ethyl acetate solution 1 under stirring
0 ml was added, the precipitate was filtered off, the filtrate was concentrated and subjected to silica gel column chromatography (toluene / ethyl acetate = 2/1), and the eluate was concentrated under reduced pressure. The residue is dissolved in 20 ml of pentane and left standing at -20 ° C for two nights. The precipitated crystals were filtered off and the solvent in the filtrate was distilled off to give crude (1-2) 3.80 as an oily substance having an optical purity of 93% ee.
get g. This compound 1.00 g (3.62 mmol), S-
(-)-1-Phenethylamine 440 μl (3.50 mmol)
Was dissolved in 3 ml of ether, 6 ml of pentane was added, and the mixture was allowed to stand at room temperature for 1 hour. The precipitated crystals are collected by filtration to obtain 1.27 g of compound 3 (melting point: 104-105 ° C). [Α] D + 11.2 ° (C = 1.00, 24.0 ° C, MeOH) Elemental analysis value (%) Calculated as C 20 H 35 NO 5 Si: C, 60.42; H, 8.87; N, 3.52 Experimental value: C , 60.34; H, 8.85; N, 3.61 1 HNMR (200M, CDCl 3 ) δ: 0.04 (3H, s); 0.05 (3H,
s); 0.84 (9H, s); 1.50 (3H, d, J = 6Hz); 2.30 to 2.60 (4
H, m); 3.65 (3H, s); 4.11 (1H, qJ = 6Hz); 7.25 ~ 7.40
(5H, m)

【0014】(2)化合物(I−2)の合成 化合物1.27gを50mlのエ−テル中に懸濁し、そ
こへ4N-HCl−酢酸エチル溶液2mlを加えて、室温で2
0分間撹拌する。不溶物を濾去し、濾液を減圧下濃縮し
て残分をペンタンにて溶解した後シリカゲル(トルエン
/酢酸エチル=2/1)にて精製して溶出液の溶媒を留
去して光学純度98%eeの目的化合物(I−2)86
1mgを得る。 [α]D +5.8°(C=4.1, 25.0℃, MeOH)1 HNMR(200M, CDCl3)δ:0.07 (3H,s); 0.08 (3H,
s); 0.85 (9H,s); 2.60 (4H,m); 3.68 (3H,s); 4.55 (1
H,m) 光学純度は同様にして、R(+)1−フェネチルアミン−
DCC−1−ヒドロクシベンズトリアゾ−ルと反応を行
ない、アミド誘導体としてHeathcockの方法に
て確認した。1 HNMR(200M, CDCl3)δ:0.03 (3H,
s); 0.07 (3H,s); 0.79 (9
H,s); 1.50 (3H,d,J=7Hz);
2.35−2.62 (4H,m); 3.69 (3
H,s); 4.50 (1H,m); 5.11
(1H,m);6.56 (1H,brd,J=7H
z); 7.32 (5H, m)
(2) Synthesis of compound (I-2) 1.27 g of compound 3 was suspended in 50 ml of ether, 2 ml of 4N-HCl-ethyl acetate solution was added thereto, and the mixture was stirred at room temperature for 2 hours.
Stir for 0 minutes. The insoluble material was removed by filtration, the filtrate was concentrated under reduced pressure, the residue was dissolved in pentane, and the residue was purified by silica gel (toluene / ethyl acetate = 2/1). Target compound (I-2) 86 with 98% ee
I get 1 mg. [Α] D + 5.8 ° (C = 4.1, 25.0 ° C., MeOH) 1 HNMR (200M, CDCl 3 ) δ: 0.07 (3H, s); 0.08 (3H,
s); 0.85 (9H, s); 2.60 (4H, m); 3.68 (3H, s); 4.55 (1
H, m) optical purity is the same as R (+) 1-phenethylamine-
The reaction was carried out with DCC-1-hydroxicbenztriazole and confirmed as an amide derivative by the method of Heatcock. 1 HNMR (200M, CDCl 3 ) δ: 0.03 (3H,
s); 0.07 (3H, s); 0.79 (9
H, s); 1.50 (3H, d, J = 7Hz);
2.35-2.62 (4H, m); 3.69 (3
H, s); 4.50 (1H, m); 5.11
(1H, m); 6.56 (1H, brd, J = 7H
z); 7.32 (5H, m)

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】一般式(I): 【化1】 (式中、R1はヒドロキシ保護基、R2は置換基を有して
いてもよい低級アルキル、*は不斉炭素原子をそれぞれ
表わす。)で示されるグルタル酸エステルのラセミ混合
溶液に(+)−デヒドロアビエチルアミンを作用させて、
R(-)グルタル酸エステルの(+)−デヒドロアビエチルア
ミン塩を生成させることを特徴とする光学活性なグルタ
ル酸エステルの回収方法。
1. General formula (I): (Wherein R 1 represents a hydroxy protecting group, R 2 represents a lower alkyl which may have a substituent, and * represents an asymmetric carbon atom, respectively) to a racemic mixed solution of the glutaric acid ester (+ ) -Dehydroabietylamine,
A method for recovering an optically active glutaric acid ester, which comprises producing a (+)-dehydroabiethylamine salt of an R (-) glutaric acid ester.
【請求項2】生成した塩を塩分解することを特徴とする
請求項1記載のR(-)グルタル酸エステルの回収方法。
2. The method for recovering R (−) glutaric acid ester according to claim 1, wherein the salt produced is decomposed.
【請求項3】母液にアミンを作用させて、S(+)グルタ
ル酸エステルのアミン塩を形成し、更に塩分解すること
を特徴とする請求項1記載のS(+)グルタル酸エステル
の回収方法。
3. The recovery of S (+) glutaric acid ester according to claim 1, wherein the mother liquor is reacted with an amine to form an amine salt of S (+) glutaric acid ester, and the salt is further decomposed. Method.
【請求項4】アミンがフェネチルアミンである請求項3
記載の方法。
4. The amine is phenethylamine.
The method described.
JP21453491A 1991-07-30 1991-07-30 Optical resolution of optically active glutaric acid ester derivatives Expired - Lifetime JP3272377B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21453491A JP3272377B2 (en) 1991-07-30 1991-07-30 Optical resolution of optically active glutaric acid ester derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21453491A JP3272377B2 (en) 1991-07-30 1991-07-30 Optical resolution of optically active glutaric acid ester derivatives

Publications (2)

Publication Number Publication Date
JPH0532680A true JPH0532680A (en) 1993-02-09
JP3272377B2 JP3272377B2 (en) 2002-04-08

Family

ID=16657327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21453491A Expired - Lifetime JP3272377B2 (en) 1991-07-30 1991-07-30 Optical resolution of optically active glutaric acid ester derivatives

Country Status (1)

Country Link
JP (1) JP3272377B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008130678A2 (en) * 2007-04-18 2008-10-30 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and process for the preparation of rosuvastatin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008130678A2 (en) * 2007-04-18 2008-10-30 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and process for the preparation of rosuvastatin
WO2008130678A3 (en) * 2007-04-18 2008-12-11 Teva Pharma Rosuvastatin intermediates and process for the preparation of rosuvastatin
EP2062903A1 (en) * 2007-04-18 2009-05-27 Teva Pharmaceutical Industries Ltd. Statin intermediates and process for the preparation of statins
JP2009538831A (en) * 2007-04-18 2009-11-12 テバ ファーマシューティカル インダストリーズ リミティド Preparation method of rosuvastatin intermediate and rosuvastatin.

Also Published As

Publication number Publication date
JP3272377B2 (en) 2002-04-08

Similar Documents

Publication Publication Date Title
KR960003810B1 (en) Process for producing optically active benzene-sulfonamide derivatives
KR0144684B1 (en) Mono esters of dicarboxylic acids and their prepartion and use
ES2930284T3 (en) Method for preparing a phenylalanine compound
JP3272377B2 (en) Optical resolution of optically active glutaric acid ester derivatives
KR950005425B1 (en) Process for enzymatic separation of optical isomers of 2-aminobutanol
GB2036744A (en) Eburnane derivatives
JP2588969B2 (en) Method for producing phenoxyethylaminopyrimidine derivative
CA1297878C (en) Process for the obtention of the ethyl ester of the apovincaminic acid
JP2531708B2 (en) Method for separating and purifying 3- (3,5-ditertiary butyl-4-hydroxyphenyl) propionic acid ester
US5149857A (en) Process for production of sulfonium compounds
JPH083143A (en) Production of 6-aralkyl substituted pyrimidine derivative
EP2448916B1 (en) Production of trans-4-aminocyclopent-2-ene-1-carboxylic acid derivatives
JP3345637B2 (en) Method for producing hydroxy compound and catalyst for producing the same
SE8205563D0 (en) PROCESS FOR THE PREPARATION OF VINCAMINIC ACID ESTERS
US5525722A (en) Process for producing biocozamycin benzoate
JP2940395B2 (en) Preparation of oxyglutarate derivatives
EP0345457B1 (en) Antinflammatory agent for the therapy of prostatic hypertrophy, a process for the preparation thereof and pharmaceutical compositions containing it
RU2083560C1 (en) Process for preparing individual stereoisomers of 4- substituted glutamic acid thioderivatives
JPH01100147A (en) Optically active malonic acid ester derivative
JPH0812658A (en) Production of sydnones
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
JPH10195075A (en) Production of z-valacyclovir
JP2002069069A (en) Derivative of 3,5,6-trihydroxyhexanoic acid ammonium salt and method of preparing the same
JPS6321661B2 (en)
JPS5940812B2 (en) Method for producing α-keto acid derivatives

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080125

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090125

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090125

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100125

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100125

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120125

Year of fee payment: 10

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120125

Year of fee payment: 10